Xarelto Side Effects. Physicians may soon add a new blood-thinning drug called Xarelto (rivaroxaban) to the standard treatment for people with “acute coronary syndrome”—and in doing so lower their risk for a subsequent heart attack or stroke, or death.
Acute coronary syndrome (ACS) is an umbrella term covering the conditions of angina and a prior history of heart attack.
“It seems a good chance that the drug will soon be approved for treatment following an acute coronary syndrome,” said Dr. Simeon Margolis, on Dec. 9 in his blog, “Your Best Health After 50” published regularly by Yahoo! Health.